# The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle Glaucoma

> **NCT04596826** · PHASE2 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 51 (actual)

## Conditions studied

- Retinal Blood Flow

## Interventions

- **DRUG:** Dronabinol 5 MG
- **DRUG:** Dronabinol 10 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04596826
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-11
- **Primary completion:** 2024-10-02
- **Final completion:** 2024-10-02
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04596826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04596826, "The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle Glaucoma". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04596826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*